BioSpace News Archive

NanoMosaic Inc. announced today that it has closed an oversubscribed $40,750,000 Series A round of financing led by RA Capital Management, joined by Insight Partners, Pura Vida Investments, Time BioVentures and Tiger Gene.

Sierra Oncology, Inc. today announced it will host an analyst and investor event on Thursday, December 16, 2021, at 12:00 pm ET.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas Equels, Chief Executive Officer of AIM, will be participating in two upcoming investor conferences.

Axcella Therapeutics today announced that Margaret Koziel, M.D., has been promoted to the role of Chief Medical Officer and added as a member of the company’s executive team.

RedHill Biopharma Ltd. today announced that because opaganib’s [1] proposed mechanism of action is not impacted by spike protein mutations, opaganib is expected to be unaffected by mutations associated with Omicron and other known variants of concern.

Pulmocide Ltd. today announced a $3.5 million investment from the Cystic Fibrosis Foundation for the development of opelconazole for lung transplant recipients.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), and RareStone LTD, today announced an exclusive licensing agreement for the development and commercialization of IMCIVREE® (setmelanotide) in China, including mainland China, Hong Kong and Macau.

Ventyx Biosciences, Inc. announced today that the first patient has been dosed in a Phase 2 randomized, placebo-controlled trial of VTX002 for the treatment of moderate-to-severe ulcerative colitis (UC).

Cue Biopharma, Inc. announced today that it will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit on Monday, December 6, 11:40 a.m. – 12:10 p.m. EST.

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to participate in 40th Annual J.P. Morgan Healthcare Conference over January 10-13, 2022.